azacitidine and rrx-001

azacitidine has been researched along with rrx-001 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fanger, G; Knox, S; Oronsky, B; Oronsky, N; Scicinski, J1
Carter, CA; Day, RM; Lybeck, M; Oronsky, A; Oronsky, B; Oronsky, N; Richard, P; Scicinski, J; Zeman, K1
Knox, SJ; Ning, S; Nolley, R; Oronsky, B; Peehl, DM; Scicinski, J; Zhao, H1

Reviews

2 review(s) available for azacitidine and rrx-001

ArticleYear
Episensitization: therapeutic tumor resensitization by epigenetic agents: a review and reassessment.
    Anti-cancer agents in medicinal chemistry, 2014, Volume: 14, Issue:8

    Topics: Animals; Antineoplastic Agents; Azacitidine; Azetidines; Benzamides; Decitabine; DNA Modification Methylases; Drug Resistance, Neoplasm; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Neoplasms; Nitro Compounds; Oxidative Stress; Pyridines; Vorinostat

2014
Addressing the elephant in the room, therapeutic resistance in non-small cell lung cancer, with epigenetic therapies.
    Oncotarget, 2016, Jun-28, Volume: 7, Issue:26

    Topics: Antibodies, Monoclonal; Azacitidine; Azetidines; Benzamides; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; CpG Islands; Disease Progression; DNA Methylation; Drug Resistance, Neoplasm; Epigenesis, Genetic; Histones; Humans; Hydralazine; Immunotherapy; Lung Neoplasms; Molecular Targeted Therapy; Mutation; Neoplasm Recurrence, Local; Nitro Compounds; Nivolumab; Prognosis; Pyridines; Treatment Outcome; Valproic Acid

2016

Other Studies

1 other study(ies) available for azacitidine and rrx-001

ArticleYear
The immunomodulatory anticancer agent, RRx-001, induces an interferon response through epigenetic induction of viral mimicry.
    Clinical epigenetics, 2017, Volume: 9

    Topics: Antineoplastic Agents; Azacitidine; Azetidines; Cell Proliferation; Cell Survival; Colonic Neoplasms; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; Dose-Response Relationship, Drug; Down-Regulation; Endogenous Retroviruses; Epigenesis, Genetic; HCT116 Cells; Humans; Immunologic Factors; Interferons; Molecular Mimicry; Nitro Compounds; Transcription, Genetic; Viral Envelope Proteins

2017